Drug intelligence / Profile preview

choline alfoscerate + ginkgo biloba extract

Development stage: Unknown
Lead developer: Daewoong Bio
Modality: Small Molecules
Administration: Oral

Overview

A combination drug consisting of choline alfoscerate and ginkgo biloba extract. Choline alfoscerate is a phospholipid that includes choline, which increases the release of acetylcholine in the brain, targeting the cholinergic system. Ginkgo biloba extract contains flavonoids and terpene lactones with antioxidant and vasoactive properties that help widen blood vessels and improve blood flow. When combined, these substances appear to have synergistic effects in improving cognitive function and slowing hearing loss.

Beyond the preview

Go deeper on choline alfoscerate + ginkgo biloba extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on choline alfoscerate + ginkgo biloba extract.

Explore the full profile